A new drug test will be introduced to this year's Tour de France by the French anti-doping agency (AFLD) in the on-going fight against dopers in the pro peloton.
Speaking to news agency Reuters France, AFLD president Pierre Bordry said that the test was for a new substance that previously could not be detected by conventional testing. However, Bordry would not reveal what the substance was, or how it would be detected.
The test isn't finalised yet, but all samples taken during this year's Tour will be stored and retroactively tested for the new substance.
Several riders' samples from last year's Tour were retroactively tested when a detection procedure for banned blood-boosting drug CERA, a form of EPO, was introduced. It was this test that caught Riccardo Ricco, Leonardo Piepoli and Bernhard Kohl, who all thought that the drug they were taking was not detectable.
Kohl met with AFLD representatives on Monday to see whether the two parties could work together in the fight against doping.
The 2009 Tour de France starts with an opening time trial in Monaco on Saturday, July 4.
Tour de France 2009 - Cycling Weekly's full coverage
Tour de France anti-doping measures explained
CERA: New scourge of the peloton
Ricco admits taking EPO before 2008 Tour de France
Kohl confirms he doped
UCI president comments on doping scandals
Thank you for reading 5 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Nigel Wynn worked as associate editor on CyclingWeekly.com, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, CyclingWeekly.com would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, n exceptional person to work with - his presence is sorely missed.
Tech of the Month July: Shimano 105 12-speed Di2 and bikes of the Tour de France
We ask if 105 is still the groupset of the people and take a look at the bikes – released and unreleased – that look set to be ridden at the tour
By Stefan Abram • Published
Fabio Jakobsen 'fairytale' keeps Quick-Step Alpha Vinyl flying high at Tour de France
Yves Lampaert might have lost the yellow jersey, but two wins in two days mean an almost-perfect Grand Départ
By Adam Becket • Published